Share on facebook Share on Twitter Share on Google Plus Share This
Back to Results

GLO Study


Title GLO: Glucose and Lactate OptiScanner Study
Therapeutic Area Intensive Care
Principal Investigator John Adam Reigh, MD
Min Age 18 Years
Gender Any
Contact John Adam, Reigh, MD
617-636-6044

Overview

The objective of this study is to demonstrate that the OptiScanner® can identify elevated and changing blood lactate levels in surgical ICU subjects.

Study Details

Inclusion Criteria

  • Be 18 years of age or older
  • Be a patient in a surgical ICU unit
  • Have a Hct level >20% within 24 hours of enrollment

Exclusion Criteria

  • Positive HcG (serum or urine) in women of child bearing potential who are not known to be surgically sterile and those that are obviously pregnant
  • On peritoneal dialysis in the last week
  • Currently receiving IVIG infusion

Study Requirements

Study requires single blood draw, in amount of 35-45mL collected form patients in ICU from either existing central/arterial line or via venipuncture.